A Randomized, Double Blind, Double Dummy, Placebo Controlled Phase III Trial to Evaluate the Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia(COCTAIL Study)

Trial Profile

A Randomized, Double Blind, Double Dummy, Placebo Controlled Phase III Trial to Evaluate the Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia(COCTAIL Study)

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Jun 2014

At a glance

  • Drugs Pitavastatin (Primary) ; Valsartan (Primary)
  • Indications Dyslipidaemias; Hypertension
  • Focus Therapeutic Use
  • Acronyms COCTAIL
  • Sponsors JW Pharmaceutical
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 27 Jun 2014 Last checked against ClinicalTrials.gov record.
    • 12 May 2014 Trial status changed to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top